6539.TWO
Price:
$55.5
Market Cap:
$1.15B
DV Biomed Co., Ltd. manufactures and sells medical-grade skin care products in Taiwan and internationally. The company provides health and slimming services; and acts as an agent of medical beauty fillers and medical beauty equipment. It also offers health food, including light and energy drinks; face care; and beauty products and services. The company was founded in 2011 and is based in Taipei, Taiwan.
Industry
Drug Manufacturers - Specialty & Generic
IPO Date
2015-10-15
Stock Exchange
TWO
Ticker
6539.TWO
According to DV Biomed Co., Ltd.’s latest financial reports and current stock price. The company's current ROE is 0.24%. This represents a change of -139.92% compared to the average of -0.60% of the last 4 quarters.
The mean historical ROE of DV Biomed Co., Ltd. over the last ten years is 20.65%. The current 0.24% ROE has changed -98.85% with respect to the historical average. Over the past ten years (40 quarters), 6539.TWO's ROE was at its highest in in the September 2022 quarter at 5.95%. The ROE was at its lowest in in the March 2025 quarter at -1.19%.
Average
20.65%
Median
20.62%
Minimum
15.56%
Maximum
25.84%
Discovering the peaks and valleys of DV Biomed Co., Ltd. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 54.40%
Maximum Annual ROE = 25.84%
Minimum Annual Increase = -36.64%
Minimum Annual ROE = 15.56%
| Year | ROE | Change |
|---|---|---|
| 2024 | 16.67% | 7.14% |
| 2023 | 15.56% | -36.64% |
| 2022 | 24.56% | -4.93% |
| 2021 | 25.84% | 3.19% |
| 2020 | 25.04% | 54.40% |
The current ROE of DV Biomed Co., Ltd. (6539.TWO) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
18.93%
5-year avg
21.53%
10-year avg
20.65%
DV Biomed Co., Ltd.’s ROE is greater than Prince Pharmaceutical Co., Ltd. (-1.50%), greater than Excelsior Biopharma Inc. (-13.77%), less than Level Biotechnology Inc. (12.44%), greater than Anxo Pharmaceutical Co., Ltd. (-4.18%), greater than Lukas Biomedical Inc. (-31.59%), greater than Bio Preventive Medicine Corp. (-24.73%), less than AViTA Corporation (7.78%), less than TCI GENE Inc. (3.64%), less than Bioray Biotech Co., Ltd (7.09%), less than Taiwan Advance Bio-Pharmaceutical Inc. (9.19%),
| Company | ROE | Market cap |
|---|---|---|
| -1.50% | $1.12B | |
| -13.77% | $1.36B | |
| 12.44% | $1.08B | |
| -4.18% | $1.21B | |
| -31.59% | $1.32B | |
| -24.73% | $1.14B | |
| 7.78% | $1.26B | |
| 3.64% | $984.26M | |
| 7.09% | $606.50M | |
| 9.19% | $1.07B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like DV Biomed Co., Ltd. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like DV Biomed Co., Ltd. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is DV Biomed Co., Ltd.'s ROE?
How is the ROE calculated for DV Biomed Co., Ltd. (6539.TWO)?
What is the highest ROE for DV Biomed Co., Ltd. (6539.TWO)?
What is the 3-year average ROE for DV Biomed Co., Ltd. (6539.TWO)?
What is the 5-year average ROE for DV Biomed Co., Ltd. (6539.TWO)?
How does the current ROE for DV Biomed Co., Ltd. (6539.TWO) compare to its historical average?